Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
about
Childhood acute myeloid leukaemiaIsolated Central Nervous System (CNS) Relapse in Paediatric Acute Promyelocytic Leukaemia: A Systematic Review.Central hypothyroidism in a pediatric case of primary acute monoblastic leukemia with central nervous system infiltration: A case reportMatrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.Central nervous system involvement at first relapse in patients with acute myeloid leukemia.Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adultsRetrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia.Pseudo-Guillain-Barré syndrome masking acute myeloid leukemia relapse: Brief report and reviewUnrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapySerum Tumor Marker Use in Patients With Advanced Solid Tumors.DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1How I treat paediatric relapsed acute myeloid leukaemia.Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia.Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.Effect of RNAi-induced down regulation of nuclear factor kappa-B p65 on acute monocytic leukemia THP-1 cells in vitro and vivo.Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China.Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse.Central nervous system disease in pediatric acute myeloid leukemia.Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease.Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
P2860
Q27005960-99CE575D-097C-402D-9E97-FD5731317132Q33666982-60EEF2FD-8A0E-4E14-A463-CAF7CF63CA08Q33879807-6B8CD230-25E8-438D-AEDB-AB473F4C1CF3Q33998763-5E790BC3-BF3A-405D-8E87-BAA49D320FEBQ34344493-20EA2C53-D26E-4BA2-BC52-B71CF4BBA503Q34629112-3C5DF8C3-1A15-41DF-BF46-00E37B5BFBC8Q35568696-89D46D4E-0016-497B-AD91-AF63530B4F11Q35690746-25804890-1EC1-44E1-AC14-1802A0C6CDE8Q35925571-191C51DC-0778-426B-9E39-68BAB339DE72Q37121665-B5AE4EA7-F225-44AA-AF20-3771566A4D5AQ37157669-6D2DAECF-2719-411D-A0E2-CAFFF01C246DQ37325612-510EE825-93C2-4268-A2D3-D04369293F2DQ38212509-4CA576E3-B5EB-4805-9CF8-7E4D59946591Q38691792-ADDA5E76-78BF-4264-AF3A-D62BF23F8B73Q38857427-400B3F0A-0492-42B3-AAA1-EBB0E905C7F2Q39477447-FA4968EE-EC40-42A2-B422-A9DF90916A5CQ40181184-16E009BD-2DC1-42D8-9F22-F55641360A2DQ40519560-8B292625-2549-49BE-B095-7EC9105663E8Q44659117-597E43B0-1849-49FD-9EE5-62D32B94F592Q44772522-E7364435-2A98-4090-83BF-D677408E3C03Q45854748-7B5B51A1-6FB0-4EF3-8683-AC9FA61033D4Q48156730-8B4F3B07-13D1-41AB-8C7C-2431FE9C34E3Q51025898-5FF6F784-50B4-432D-8673-DAECE212E140Q51137027-91D6AE9E-A0A4-4F5E-81B4-350418C5D856Q52887508-D19C1843-E529-4808-B398-36B99847ADA2
P2860
Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Risk factors and therapy for i ...... iatric acute myeloid leukemia.
@ast
Risk factors and therapy for i ...... iatric acute myeloid leukemia.
@en
type
label
Risk factors and therapy for i ...... iatric acute myeloid leukemia.
@ast
Risk factors and therapy for i ...... iatric acute myeloid leukemia.
@en
prefLabel
Risk factors and therapy for i ...... iatric acute myeloid leukemia.
@ast
Risk factors and therapy for i ...... iatric acute myeloid leukemia.
@en
P2093
P356
P1476
Risk factors and therapy for i ...... iatric acute myeloid leukemia.
@en
P2093
Beverly J Lange
Donna L Johnston
Robert B Gerbing
Todd A Alonzo
William G Woods
P304
P356
10.1200/JCO.2005.02.7482
P407
P577
2005-12-01T00:00:00Z